Aifeng Zhang Selected Research

Aifeng Zhang Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 12/2007
10	Epilepsy (Aura) 01/2022 - 01/2016
4	Neuroinflammatory Diseases 01/2021 - 08/2018
4	Breast Neoplasms (Breast Cancer) 11/2020 - 11/2014
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020 - 08/2018
3	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2018
3	Long QT Syndrome 01/2016 - 12/2008
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Temporal Lobe Epilepsy 01/2022 - 08/2018
2	Wounds and Injuries (Trauma) 01/2022 - 10/2019
2	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2021
2	Cognitive Dysfunction 10/2020 - 01/2017
2	Ischemia 01/2020 - 01/2018
2	Seizures (Absence Seizure) 01/2019 - 11/2017
2	Inflammation (Inflammations) 01/2019 - 04/2014
2	Stomach Neoplasms (Stomach Cancer) 06/2018 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2014
2	Cardiac Arrhythmias (Arrythmia) 01/2017 - 01/2014
2	Ovarian Neoplasms (Ovarian Cancer) 08/2009 - 10/2008
1	Cerebral Hemorrhage 01/2021
1	Carcinogenesis 01/2021
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 01/2019
1	Anorexia Nervosa 01/2019
1	Endometriosis 01/2019
1	Lung Neoplasms (Lung Cancer) 06/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Ischemic Stroke 01/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Adenocarcinoma 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Syncope (Fainting) 03/2016
1	Stroke (Strokes) 01/2016
1	Abdominal Obesity 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Hypertriglyceridemia 01/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015

Drug/Important Bio-Agent (IBA)

5	Pentylenetetrazole (Metrazol)IBA 10/2020 - 01/2016
4	Pilocarpine (Ocusert)FDA LinkGeneric 01/2022 - 08/2018
4	Proteins (Proteins, Gene)FDA Link 08/2018 - 12/2008
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2019
3	Peptides (Polypeptides)IBA 11/2020 - 11/2014
2	erucylphosphocholineIBA 01/2022 - 01/2020
2	CuprizoneIBA 10/2021 - 01/2021
2	BRBP1 peptideIBA 11/2020 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	ElementsIBA 01/2018 - 01/2018
2	Ether (Diethyl Ether)IBA 01/2016 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 12/2007
2	Decitabine FDA Link 08/2009 - 10/2008
1	6-methyladenineIBA 01/2022
1	Galectins (Galectin)IBA 01/2022
1	Neuropeptide YIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2021
1	Protective AgentsIBA 10/2021
1	CholesterolIBA 10/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2021
1	ferric oxide (iron oxide)IBA 11/2020
1	monomethoxypolyethylene glycol (MPEG)IBA 11/2020
1	Contrast MediaIBA 11/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2020
1	Dinoprostone (PGE2)FDA Link 10/2020
1	Celecoxib (Celebrex)FDA Link 10/2020
1	CreatinineIBA 01/2020
1	AntagomirsIBA 10/2019
1	AcidsIBA 10/2019
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 01/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 08/2018
1	Minocycline (Cyclops)FDA LinkGeneric 08/2018
1	Metalloproteases (Metalloproteinases)IBA 08/2018
1	DisintegrinsIBA 08/2018
1	apatinibIBA 06/2018
1	Therapeutic UsesIBA 06/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	LigandsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	DNA Methyltransferase 3AIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Calcibiotic Root Canal SealerIBA 01/2018
1	alisol BIBA 03/2017
1	GlucocorticoidsIBA 01/2017
1	SodiumIBA 01/2017
1	Gefitinib (Iressa)FDA Link 11/2016
1	PlatinumIBA 11/2016
1	5,5-dimethyl-1,2,3-cyclohexanetrione 1,2-dioxime 3-thiosemicarbazoneIBA 01/2016
1	Cell-Penetrating PeptidesIBA 01/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 06/2018 - 11/2016
2	Therapeutics 01/2017 - 11/2016
1	Thrombectomy 01/2021
1	Precision Medicine 01/2018